FFR

TCT 2018 | FAST-FFR: FFR derivado de la angiografía, sin hiperemia y sin necesidad de cruzar la lesión

TCT 2018 | FAST-FFR: Angiography-Derived FFR Without Hyperemic Stimulus or Invasive Guidewire Placement

All over the world, functional lesion measurement remains underutilized due to the need for a hyperemic stimulus (which may be avoided with instantaneous wave-free ratio [iFR]) and, above all, the invasiveness of guidewire placement (crossing the intended lesion) for the measurement. These guidewires have improved a lot, but they still lack the navigating capacity of<a href="https://solaci.org/en/2018/10/08/tct-2018-fast-ffr-angiography-derived-ffr-without-hyperemic-stimulus-or-invasive-guidewire-placement/" title="Read more" >...</a>

FUTURE: una piedra en el zapato para el FFR y más preguntas que respuestas

ESC 2018 | FUTURE: A Thorn in FFR and More Questions than Answers

As observed at the preliminary analysis that motivated the FUTURE trial early termination, the use of fractional flow reserve (FFR) to guide revascularization in an unselected population with multivessel disease was associated to twice the mortality rate in one year, with no beneficial impact on other end points. Even though the combined end point of<a href="https://solaci.org/en/2018/08/28/esc-2018-future-a-thorn-in-ffr-and-more-questions-than-answers/" title="Read more" >...</a>

El FFR ahorra síntomas a los pacientes y costos a los financiadores de salud

FFR vs Angiography Guided CABG

In the daily practice and in randomized studies such as Syntax or Freedom, most cardiovascular surgeons across the world use angiography guided CABG to teat 50% coronary stenosis. Many of these lesions might not be functionally significant. There is abundant evidence in favor of fractional flow reserve (FFR) guided PCI, but FFR guided CABG is<a href="https://solaci.org/en/2018/06/27/ffr-vs-angiography-guided-cabg/" title="Read more" >...</a>

EuroPCR 2018 | Compare-Acute: FFR o angioplastia primaria en el seguimiento a 2 años de la revascularización completa

EuroPCR 2018 | Compare-Acute: FFR or Primary Angioplasty at a 2-Year Follow-Up After Complete Revascularization

Recent studies in patients undergoing acute myocardial infarction showed that a complete revascularization strategy in an acute or subacute setting, whether it be guided through angiography (PRAMI, CvLPRIT) or fractional flow reserve (FFR) (PRIMULTI, COMPARE-ACUTE), improves the combined endpoint of major adverse cardiac events (MACE) when compared with treatment of the culprit artery only. Based<a href="https://solaci.org/en/2018/05/29/europcr-2018-compare-acute-ffr-or-primary-angioplasty-at-a-2-year-follow-up-after-complete-revascularization/" title="Read more" >...</a>

El FFR reduce la muerte y el infarto comparado con el tratamiento médico

EuroPCR 2018 | FFR Reduces Death and Infarction Rates Compared with Medical Treatment

Pooled data from the most important recently published studies (FAME 2, Compare-Acute, and DANAMI3-PRIMULTI) conclude that there is a significant difference in favor of fractional flow reserve (FFR) as regards hard endpoints. Coronary revascularization guided by FFR reduces the risk of death and infarction when compared with optimal medical treatment in patients with stable and<a href="https://solaci.org/en/2018/05/28/europcr-2018-ffr-reduces-death-and-infarction-rates-compared-with-medical-treatment/" title="Read more" >...</a>

FAME 2: el FFR muestra su beneficio a 5 años en puntos duros

EuroPCR 2018 | FAME 2: FFR Shows 5-Year Benefit for Hard Endpoints

After a 5-year follow-up, and for the first time, functional assessment with fractional flow reserve (FFR) showed clear benefit for a hard endpoint: acute myocardial infarction. Use of FFR in patients with stable coronary artery disease so as to identify hemodynamically significant lesions in order to restrict angioplasty treatment to them has long-term benefits compared<a href="https://solaci.org/en/2018/05/28/europcr-2018-fame-2-ffr-shows-5-year-benefit-for-hard-endpoints/" title="Read more" >...</a>

Registro SCAAR a 10 años: el FFR mejora la toma de decisiones a muy largo plazo

EuroPCR 2018 | SCAAR Registry at 10 years: FFR improves decision making in the long term

The SCAAR registry aimed at showing the differences in mortality at very long term when using functional assessment of coronary lesions (with FFR or iFR) in patients with chronic stable angina. The study compared 3460 patients assessed with FFR/iFR against 21221 patients undergoing PCI based on angiography, between January 2005 and March 2015.   As<a href="https://solaci.org/en/2018/05/24/europcr-2018-scaar-registry-at-10-years-ffr-improves-decision-making-in-the-long-term/" title="Read more" >...</a>

Routine FFR/iFR Reclassifies Treatment Strategies in Half of Cases

Routine invasive physiology assessment at time of angiography reclassifies treatment strategies in a big number of patients with lesions in 2 or 3 vessels, according to the multicenter prospective study DEFINE REAL, recently published in&nbsp;JACC Cardiovascular Interventions. The information obtained by measuring&nbsp;fractional flow reserve (FFR)&nbsp;or&nbsp;instantaneous wave free ratio (iFR)&nbsp;made interventionists modify their original plans in<a href="https://solaci.org/en/2018/03/07/routine-ffr-ifr-reclassifies-treatment-strategies-in-half-of-cases/" title="Read more" >...</a>

Impacto del FFR post stent ¿dato útil o solo una curiosidad?

The diagnostic performance of the iFR makes the FFR tremble

Despite the evidence, most stable patients continue to be managed based on coronary angiography and, worse, often without a prior non-invasive functional study. With the introduction of the FFR, we left the &#8220;anatomical&#8221; era for the &#8220;functional&#8221; era in the catheterization room, which has been proven to improve patients prognosis and, as if that were<a href="https://solaci.org/en/2018/02/26/the-diagnostic-performance-of-the-ifr-makes-the-ffr-tremble/" title="Read more" >...</a>

Top